RC
| |
RA CAPITAL MANAGEMENT, L.P.13F | |
RA CAPITAL MANAGEMENT, L.P. | |
Last update 2025-05-16 | 85 Stocks (11 new) |
Value $5.99 Bil | Turnover 12 % |
RA CAPITAL MANAGEMENT, L.P. Top Holdings of 2025-03-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ASND | Ascendis Pharma AS | 10,281,496 | 1,602,474.0 | +1.67% | 26.760 | +0.44% | 17.030 | +22.39% | +22.15% | 10,172.6 | Biotechnology | |
PCVX | Vaxcyte Inc | 12,189,149 | 460,262.3 | +40.28% | 7.690 | +2.21% | 9.450 | +10.79% | -59.13% | 4,316.5 | Biotechnology | |
RYTM | Rhythm Pharmaceuticals Inc | 6,084,412 | 322,291.3 | 0% | 5.380 | 0% | 9.560 | +12.84% | +16.36% | 4,144.3 | Biotechnology | |
JANX | Janux Therapeutics Inc | 11,189,693 | 302,121.7 | +7.95% | 5.050 | +0.37% | 18.910 | +2.77% | -54.33% | 1,446.8 | Biotechnology | |
NAMS | NewAmsterdam Pharma Co NV | 10,138,938 | 207,544.1 | +14.63% | 3.470 | +0.44% | 9.030 | +32.06% | -22.10% | 2,247.7 | Biotechnology | |
ACLX | Arcellx Inc | 3,036,527 | 199,196.2 | +8.94% | 3.330 | +0.27% | 5.510 | +24.18% | -13.21% | 3,667.9 | Biotechnology | |
EWTX | Edgewise Therapeutics Inc | 8,909,091 | 196,000.0 | 0% | 3.270 | 0% | 8.470 | +13.32% | -51.24% | 1,369.7 | Biotechnology | |
RNA | Avidity Biosciences Inc | 6,300,408 | 185,988.0 | 0% | 3.110 | 0% | 5.230 | +21.47% | +0.58% | 3,525.2 | Biotechnology | |
WVE | WAVE Life Sciences Ltd | 18,202,009 | 147,072.2 | 0% | 2.460 | 0% | 11.810 | +24.11% | -43.82% | 1,081.2 | Biotechnology | |
ETNB | 89bio Inc | 19,889,683 | 144,598.0 | +40.31% | 2.410 | +0.69% | 13.620 | +106.00% | +27.24% | 1,452.5 | Biotechnology |
RA CAPITAL MANAGEMENT, L.P.'s Historical Top Holdings Breakdowns
RA CAPITAL MANAGEMENT, L.P.'s Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
LEGN | Legend Biotech Corp | 2025-03-31 | Sold Out Sold Out | -3.25% | 31.43 ($35.86) 39.7 | $37.46 | 4.46% | Sold Out | 0 | -7,506,934 | |
PCVX | Vaxcyte Inc | 2025-03-31 | Add Add | +2.21% | 37.76 ($79.95) 92.13 | $33.36 | -58.27% | Add 40.28% | 12,189,149 | 3,499,959 | |
SION | Sionna Therapeutics Inc | 2025-03-31 | New Buy New Buy | +1.82% | 0 ($15.65) 22.24 | $21.39 | 36.68% | New holding | 10,445,322 | 10,445,322 | |
XBI | SPDR Biotech ETF | 2025-03-31 | Sold Out Sold Out | -1.47% | 81.1 ($89.38) 94.7 | $84.73 | -5.20% | Sold Out | 0 | -1,228,240 | |
IRON | Disc Medicine Inc | 2025-03-31 | New Buy New Buy | +1.31% | 49.64 ($55.6) 63.82 | $53.19 | -4.33% | New holding | 1,577,106 | 1,577,106 | |
AXSM | Axsome Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -1.13% | 80.05 ($113.93) 137.75 | $108.85 | -4.46% | Sold Out | 0 | -1,000,000 | |
VRNA | Verona Pharma PLC | 2025-03-31 | Sold Out Sold Out | -1.09% | 44.81 ($59.82) 69.63 | $87.08 | 45.57% | Sold Out | 0 | -1,766,830 | |
GERN | Geron Corp | 2025-03-31 | Add Add | +0.80% | 1.59 ($2.44) 3.6 | $1.37 | -43.85% | Add 101.2% | 60,379,366 | 30,369,830 | |
PRAX | Praxis Precision Medicines Inc | 2025-03-31 | Sold Out Sold Out | -0.78% | 33.55 ($62.45) 90.77 | $46.49 | -25.55% | Sold Out | 0 | -761,955 | |
ETNB | 89bio Inc | 2025-03-31 | Add Add | +0.69% | 6.1 ($8.74) 11.66 | $10.06 | 15.10% | Add 40.31% | 19,889,683 | 5,714,285 |
RA CAPITAL MANAGEMENT, L.P. Total Holding History ($B)
RA CAPITAL MANAGEMENT, L.P.'s Asset Allocation
RA CAPITAL MANAGEMENT, L.P. Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
RA CAPITAL MANAGEMENT, L.P.'s Hypothetical Growth since 2025-03-31
RA CAPITAL MANAGEMENT, L.P.'s Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
RA CAPITAL MANAGEMENT, L.P.'s Holdings Heat Map
Size field:
RA CAPITAL MANAGEMENT, L.P.'s Holdings Bubble Chart
RA CAPITAL MANAGEMENT, L.P. News
- 1